Provider review
MEDVi review: pricing, pharmacy, and evidence status
Released: · Last reviewed: · By Dr. Parmis
MEDVi offers GLP-1 medications through telehealth. Every price, credential and pharmacy claim below is labeled by evidence status and read date.
MEDVi has no usable published price on file. It names its dispensing pharmacy. It is not scored in the November 20, 2026 re-score because its pages could not be read.
Rank and score
MEDVi is not scored in the November 20, 2026 re-score: MEDVi's compounded prices render as unfilled template placeholders without a browser (portfolio re-read November 20, 2026). Giving it points, or zeros, for pages we could not read would misstate what it discloses. See the methodology.
FDA record: FDA warning letter 721455, dated February 20, 2026 (False & Misleading Claims/Misbranded (Telehealth)). FDA's index showed no close-out letter when read on November 20, 2026.
Pricing by plan
| Medication | Formulation | Plan | Price | Source | Evidence |
|---|---|---|---|---|---|
| semaglutide | compounded injectable | month-to-month | $299/mo | not published · read 2026-07-06 | Unverified — no source on file |
2 price points for MEDVi appeared only in a third-party source and have been withheld from this table and from any ranking or total until captured directly from the provider. See the source ledger for the withheld records.
"Provider reported" means the figure comes from the company's own site or intake flow and has not been independently corroborated by GLP Ranked.
Clinical model
Network label, no specific P.C.: “Medical treatment is provided by “CareGLP Affiliated P.C.s,” and OpenLoop Health, affiliated networks for medical professional corporations and associations.” (home.medvi.org, read 2026-11-10)
Accreditation: we have not verified any accreditation or certification claim for MEDVi against the issuing body. If a program cites one (for example LegitScript), check the issuer's public lookup before you rely on it.
Pharmacy & compliance
Names partner pharmacies with addresses: Triad Rx (Daphne, AL), RedRock Pharmacy (St. George, UT) and Beaker Pharmacy & Compounding (McKinney, TX) (read 2026-11-10) Pharmacy transparency is worth 15 of 100 points under our v4.1 rubric.
State availability
State-by-state availability is not independently verified.
Who this suits — and who it doesn't
MEDVi may suit patients who want a standard-dose program and value that the dispensing pharmacy is named up front.It is a weaker fit for patients who need written proof of pharmacy accreditation before paying; ask the company for it.
Terms to check before you pay: cancellation and refund terms could not be read in this re-score; published support response times: not published.
Sources
- FDA warning letter 721455 (False & Misleading Claims/Misbranded (Telehealth)) — Regulator letter, captured 2026-11-20
- FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (content current October 1, 2026) — Regulator page, captured 2026-11-20
- FDA: Compounding: Inspections, Recalls, and other Actions (content current October 22, 2026) — Regulator list, captured 2026-11-21
Cite this page
GLP Ranked. "MEDVi review: pricing, pharmacy, and evidence status." https://glpranked.com/providers/medvi/
GLP Ranked. "MEDVi review: pricing, pharmacy, and evidence status." https://glpranked.com/providers/medvi/